HXPP(002228)2025-04-25 16:05Financial Performance - The company's operating revenue for Q1 2025 was ¥2,495,816,232.03, representing a decrease of 8.75% compared to the same period last year[5]. - Net profit attributable to shareholders increased by 48.23% to ¥49,760,003.08, driven by profit growth from certain subsidiaries[5]. - Basic earnings per share rose by 33.33% to ¥0.04, while diluted earnings per share also increased by 33.33% to ¥0.04[5]. - Total operating revenue decreased to ¥2,495,816,232.03 from ¥2,735,156,301.84, representing a decline of approximately 8.8% year-over-year[24]. - Total operating costs decreased to ¥2,440,467,767.08 from ¥2,708,914,639.99, a reduction of about 10% year-over-year[24]. - Net profit increased to ¥48,287,947.10 from ¥27,936,357.36, showing a growth of approximately 73% year-over-year[25]. - Total comprehensive income amounted to CNY 49,218,765.37, an increase from CNY 13,056,759.10 in the previous period[26]. - Basic and diluted earnings per share increased to CNY 0.04 from CNY 0.03[26]. Cash Flow and Liquidity - Cash flow from operating activities decreased by 27.23% to ¥154,753,991.32, indicating a decline in cash generation[5]. - The company reported a cash balance of ¥776,076,494.42 as of March 31, 2025, an increase from ¥566,741,451.03 at the beginning of the period, reflecting a growth of approximately 37%[19]. - Net cash flow from operating activities was CNY 154,753,991.32, down from CNY 212,650,037.31 in the previous period[29]. - Cash inflow from operating activities totaled CNY 2,575,875,665.47, compared to CNY 2,610,254,864.40 last year[28]. - Cash outflow from operating activities was CNY 2,421,121,674.15, slightly up from CNY 2,397,604,827.09[29]. - Net cash flow from investing activities was negative CNY 20,902,329.22, an improvement from negative CNY 49,631,740.80 in the previous period[29]. - Cash inflow from financing activities was CNY 225,798,419.84, compared to CNY 228,780,474.28 last year[30]. - Cash outflow from financing activities decreased to CNY 179,786,149.73 from CNY 330,968,435.53[30]. - The ending balance of cash and cash equivalents was CNY 504,000,214.25, up from CNY 398,046,508.41[30]. Assets and Liabilities - Total assets at the end of the reporting period were ¥7,587,588,976.25, down 1.69% from the end of the previous year[5]. - The company's total assets decreased to ¥7,587,588,976.25 from ¥7,717,817,381.41, a decline of about 1.7%[22]. - Total liabilities decreased to ¥4,269,346,385.79 from ¥4,374,619,157.74, reflecting a reduction of approximately 2.4%[21]. - The company's equity attributable to shareholders decreased slightly to ¥3,180,113,621.04 from ¥3,185,960,509.40, a decrease of about 0.25%[22]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 25,488[12]. - The company approved the cancellation of 27,299,927 shares from the second phase of its share repurchase program[17]. - The company held a shareholder meeting on February 13, 2025, to elect the new board and management personnel[16]. Other Financial Metrics - The weighted average return on equity improved to 1.56%, up from 1.02% in the previous year[5]. - The company experienced a 93.24% increase in other non-current assets, mainly due to prepayments not reaching settlement conditions[10]. - Other income increased by 274.35% compared to the previous year, primarily due to gains from equity acquisitions[11]. - The company’s other receivables increased to ¥77,253,289.37 from ¥63,990,931.46, marking an increase of about 21%[19]. - The company’s prepayments decreased to ¥30,044,705.23 from ¥37,500,991.89, reflecting a decline of approximately 20%[19]. - The company’s financing receivables rose to ¥410,636,558.21 from ¥357,417,480.17, indicating an increase of about 14.9%[19]. - Research and development expenses decreased to ¥62,740,532.31 from ¥70,308,976.86, a decline of approximately 10.5% year-over-year[24]. - The company reported a credit impairment loss of ¥10,516,612.14, compared to a loss of ¥10,225,161.93 in the previous period[25]. Accounting and Audit - The company is undergoing changes in accounting estimates as approved in the board meeting on February 28, 2025[18]. - The company did not undergo an audit for the first quarter report[31].